Collecting and deploying poverty-related data is an important starting point for leveraging data regarding social determinants of health in precision medicine. However, we must rethink how we collect and deploy such data. Current modes of collection yield imprecise data that is unsuited for research. Better data can be collected by cross-referencing other sources such as employers and public benefit programs, and by incentivizing and encouraging patients and providers to provide more accurate information. Data thus collected can be used to provide appropriate individual-level clinical and non-clinical care, and to systematically determine what share of social resources healthcare should consume.
Get full access to this article
View all access options for this article.
References
1.
See, e.g., C.Konnoth, “Health Information Equity,”University of Pennsylvania Law Review165, no. 6 (2017): 1317-1376.
2.
P.Braveman and L.Gottlieb, “The Social Determinants of Health: It's Time to Consider the Causes of the Causes,”Public Health Reports129, no. 2 (2014): 19-31.
See Konnoth, supra note 1 (discussing 2008, 2010, and 2011 legislation).
5.
Panel on Poverty and Family Assistance: Concepts, Information Needs, and Measurement Methods, National Research Council, Measuring Poverty: A New Approach (Washington, DC: The National Academies Press, 1995) (hereafter NRC Report).
J.Cubanski and T.Neuman, “Medicare's Income-Related Premiums: A Data Note,”Henry J. Kaiser Family Foundation, July3, 2015, available at <http://kff.org/medicare/issue-brief/medicares-income-related-premiums-a-data-note/> (last visited July 10, 2018); see also “Means-Testing of the Medicare Part B Premium,”National Committee to Preserve Social Security and Medicare (July2009), available at <http://www.ncpssm.org/Document/ArticleID/777> (last visited July 10, 2018) (“[T]he Social Security Administration (SSA) automatically determines the amount of the Medicare Part B premium using tax records filed with the Internal Revenue Service two or three years previously.”).
J.Pomeranz, “Participatory Workforce Wellness Programs: Reward, Penalty, and Regulatory Conflict,”Milbank Quarterly93, no. 2 (2015): 301-318. Admittedly, these programs are not without controversy. See Id.
21.
Merit-Based Incentive Payment System Overview, Quality Payment Program, available at <https://qpp.cms.gov/mips/overview> (last visited July 10, 2017).
22.
Memorandum Opinion, AARP v. United States Equal Employment Opportunity Commission, 226 F.Supp.3d 7 (U.S.D.C. 2016).
23.
C.Konnoth, “Classification Standards for Health Information: Ethical and Practical Approaches,”Washington and Lee Law Review Online72, no.3 (2016): 395-405 (suggesting an approach that allows patients to customize privacy preferences).
See, e.g., N.MacReady, “One in Five Patients Report Discrimination by Providers,”Medscape Medical News, WebMd, December18, 2017, available at <https://www.medscape.com/viewarticle/890229> (last visited July 10, 2018).
26.
J.C.Newman, et al., “The Differential Effects of Face-to-Face and Computer Interview Modes,”American Journal of Public Health92, no. 2 (2002): 294-297.
27.
See Konnoth, supra note 1 (explaining the learning health system).
28.
B.A.McCabe, “Barriers to Adherence in a Free Medication Program for Low Income Individual with Type 2 Diabetes,”LSU Doctoral Dissertations (2003): 3679; J.E.Kurlanderet al., “Cost-Related Nonadherence to Medications Among Patients with Diabetes and Chronic Pain,”Diabetes Care32, no. 12 (2009): 2143-2148.
29.
A.R.Scott, et al., “Surgical Follow-up Costs Disproportionately Impact Low Income Patients,”Journal of Surgical Research199, no. 1 (2015): 32-38.
30.
D.Delia, “Post-Discharge Follow-up Visits and Hospital Utilization by Medicare Patients, 2007-2010,”Medicare and Medicaid Research Review4, no. 2 (2014): E1-E19.
31.
C.A.Jones, “Cardiovascular Disease Risk Among the Poor and Homeless — What We Know So Far,”Current Cardiology Reviews5, no. 1 (2009): 69-77.
32.
See C.Konnoth, Medicalization and the New Civil Rights (Working Draft, on file with author).
33.
J.Fox and R.Thompson, “Clinical Decision Support Systems: A Discussion of Quality, Safety and Legal Liability Issues, Proceedings AMIA Symposium (2002): 265-269.
34.
C.Konnoth, Medicalization, supra note 32.
35.
M. J.Mugaveroet al., “The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control,”Clinical Infectious Diseases57, no. 8 (2013): 1164-1171.
36.
B. W.Pence, et al., “Falling through the Cracks: The Gaps between Depression Prevalence, Diagnosis, Treatment, and Response in HIV Care,”AIDS26, no. 5 (2012): 658.
The kind of approach I seek to suggest is analogous to the one here. A. A.Markovitzet al., “Risk Adjustment May Lessen Penalties on Hospitals Treating Complex Cardiac Patients under Medicare's Bundled Payments,”Health Affairs36, no. 12 (2017).
42.
F. E.Baumet al, “Changes Not for the Faint-hearted: Reorienting Health Care Systems toward Health Equity through Action on the Social Determinants of Health,”American Journal of Public Heath99, no. 11 (1999): 1967-1974.
43.
See, e.g., A. N.Bazzanoet al., “Factors Associated with Vitamin D Status of Low-Income Hospitalized Psychiatric Patients: Results of a Retrospective Study,”Neuropsychiatric Disease and Treatment12 (2016): 2973-2980.
